Pharmacological Preventive Potential Among Attenders at Vascular Screening: Findings from the VIVA Trial.

CONCLUSION: Future vascular screening programmes might benefit from tailoring information to subgroups who are more likely to benefit from screening but less likely to accept an offer.
PMID: 32063462 [PubMed - as supplied by publisher]

Source: PubMed: Eur J Vasc Endovasc ... - February 12, 2020 Category: Surgery Authors: Hansen TB, Søgaard R, Lindholt JS Tags: Eur J Vasc Endovasc Surg Source Type: research